LiSyM: The better way to manage your data
Free and open platform for easier research data management
Latest additions
Isonimesulide and Its Carborane Analogues as Isoform‐Selective COX Inhibitors and Antitumor Agents
Publication - added 4 minutes agoSynthesis and In Vitro Biological Evaluation of p-Carborane-Based Di-tert-butylphenol Analogs
Publication - added 10 minutes agoMinutes from workshop 1 “Towards concordant multiomics of liver” at LiSym status seminar March 2023, Dresden
Document - added about 1 month agoStatusSeminar2023picture_all
Document - added about 2 months agoShell engineering in soft alginate‐based capsules for culturing liver spheroids
Publication - added 2 months agoHepatocyte polarity model
Model - added 2 months agoAgenda of LiSyM-Cancer Status Seminar 28.-29.03.2023, Dresden
Document - added 2 months agoModelling asssay II Lucarelli paper
Modelling analysis - added 2 months agoexp assay I Lucarelli paper
Assay - added 2 months agoStudy about Smad complexes in liver-derived cells
Study - added 2 months ago
Find content
LiSyM (Liver Systems Medicine) represents a research network of German centers and institutions, brought together by a 20 Million Euro funding program of the German Government, in which mathematicians, modelers, pharmacologists, molecular biologists and clinical scientists work together to develop a Systems Medicine approach to study early and advanced liver disease.
The aim of this unique research program is to acquire and use new experimental data and data from existing data bases to build computational models that facilitate decision making at the patient's bedsite and to predict the actions of new medicines in the treatment of metabolic liver disease.